NCT06757777View on ClinicalTrials.gov

Evaluation of Remnant Cholesterol Levels and Monocyte-to-HDL-cholesterol Ratio As Predictors of Coronary Artery Disease Severity in Patients with Acute Coronary Syndrome

Not yet recruitingOBSERVATIONAL
Enrollment

54

Participants

Timeline

Start Date

February 8, 2025

Primary Completion Date

February 8, 2026

Study Completion Date

March 8, 2026

Conditions
Acute Coronary SyndromeACS (acute Coronary Syndrome)Monocyte to HDL Cholesterol RatioSTEMINon STEMI
All Listed Sponsors
lead

Assiut University

OTHER

NCT06757777 - Evaluation of Remnant Cholesterol Levels and Monocyte-to-HDL-cholesterol Ratio As Predictors of Coronary Artery Disease Severity in Patients with Acute Coronary Syndrome | Biotech Hunter | Biotech Hunter